Sales Growth YoY (Last 12 Months): ENDRA Corp (NDRA)

Brandmark of endrainc.com (NDRA)

ENDRA Life Sciences is implementing affordable hepatic steatosis screening via its proprietary TAEUS system, transforming standard ultrasound into a precision diagnostic tool. The Last Twelve Months (LTM) trading revenue growth reflects current dynamics, with the latest figure standing at 0.00. Business resilience depends on global software recognition, while operational efficiency is maintained through contract manufacturing and outsourced clinical trial management.

ENDRA Life Sciences Inc (NDRA) - Sales Growth YoY (Last Twelve Months) from 02/11/2024 to 11/18/2026

ENDRA Life Sciences Inc. - analytical breakdowns and key metrics (NDRA)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:ENDRA (NDRA)
Original product of endrainc.com

ENDRA Life Sciences is advancing liver diagnostics through the implementation of its unique TAEUS system, whose market expansion directly determines the business's sustainability. By analyzing the year-over-year sales trend over the last 12 months, an investor can track revenue dynamics on a rolling basis, making it possible to identify a slowdown in commercial flows prior to the publication of reports and assess the company's fundamental margin of safety.